Published in Hypertension on August 01, 2000
Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest (2004) 1.87
11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. Physiol Rev (2013) 1.60
Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res (2008) 1.15
Microsatellite tandem repeats are abundant in human promoters and are associated with regulatory elements. PLoS One (2013) 1.04
Genetic variants in the renin-angiotensin-aldosterone system and salt sensitivity of blood pressure. J Hypertens (2010) 1.03
Hsd11b2 haploinsufficiency in mice causes salt sensitivity of blood pressure. Hypertension (2011) 0.90
Failure to downregulate the epithelial sodium channel causes salt sensitivity in Hsd11b2 heterozygote mice. Hypertension (2012) 0.89
Effect of polymorphism on expression of the neuropeptide Y gene in inbred alcohol-preferring and -nonpreferring rats. Neuroscience (2005) 0.88
(TG/CA)n repeats in human gene families: abundance and selective patterns of distribution according to function and gene length. BMC Genomics (2005) 0.87
Exploring the relationship between polymorphic (TG/CA)n repeats in intron 1 regions and gene expression. Hum Genomics (2009) 0.87
Genetics of stress response and stress-related disorders. Dialogues Clin Neurosci (2006) 0.86
Deletions within a CA-repeat-rich region of intron 4 of the human SP-B gene affect mRNA splicing. Biochem J (2005) 0.84
Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized vitiligo. J Interferon Cytokine Res (2013) 0.81
In silico structure-function analysis of pathological variation in the HSD11B2 gene sequence. Physiol Genomics (2010) 0.76
Expoldb: expression linked polymorphism database with inbuilt tools for analysis of expression and simple repeats. BMC Genomics (2006) 0.75
Structural features of conopeptide genes inferred from partial sequences of the Conus tribblei genome. Mol Genet Genomics (2015) 0.75
Functional Mechanisms of Microsatellite DNA in Eukaryotic Genomes. Genome Biol Evol (2017) 0.75
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Chemical characterization of a neural cell adhesion molecule purified from embryonic brain membranes. J Biol Chem (1982) 5.87
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab (2001) 4.47
Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet (2001) 4.14
Metformin in non-alcoholic steatohepatitis. Lancet (2001) 3.63
Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis (1975) 3.33
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. Proc Natl Acad Sci U S A (1985) 3.22
Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry (2001) 2.84
Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int (2006) 2.79
Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet (1997) 2.78
Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart (1997) 2.65
Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) (1998) 2.59
HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A (1984) 2.56
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol (2000) 2.47
Immunoradiometric versus enzymatic renin assay: results of the Italian Multicenter Comparative Study. Italian Multicenter Study for Standardization of Renin Measurement. J Hypertens (1995) 2.44
Does central obesity reflect "Cushing's disease of the omentum"? Lancet (1997) 2.34
Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci U S A (1986) 2.34
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab (2011) 2.16
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance? Clin Endocrinol (Oxf) (2008) 2.15
Uric acid metabolism and tubular sodium handling. Results from a population-based study. JAMA (1993) 2.10
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest (2001) 2.10
Blot hybridisation analysis of genomic DNA. J Med Genet (1984) 2.09
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol (2000) 2.01
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int (2007) 2.01
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol (1994) 2.01
Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med (1996) 1.99
Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. Lancet (1988) 1.97
Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella typhi. J Clin Microbiol (1980) 1.90
Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A (1984) 1.89
Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann Rheum Dis (2008) 1.86
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest (1996) 1.83
Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens (1996) 1.83
AME position statement on adrenal incidentaloma. Eur J Endocrinol (2011) 1.82
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism. Clin Chem (1998) 1.76
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). J Biol Chem (1989) 1.69
Nonelectrolyte diffusion across lipid bilayer systems. J Gen Physiol (1976) 1.59
Two steroid 21-hydroxylase genes are located in the murine S region. Nature (1985) 1.58
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer (1996) 1.57
Persistence of Mycobacterium bovis in cattle. Trends Microbiol (1994) 1.56
Mineralocorticoid excess and inhibition of 11 beta-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol (Oxf) (1992) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Renal function and blood pressure response to dietary salt restriction in normotensive men. Hypertension (1996) 1.56
Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol (2007) 1.55
Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol (2001) 1.55
Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J Biol Chem (1989) 1.54
Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am J Hum Genet (1986) 1.54
A waterborne outbreak of gastroenteritis in adults associated with Escherichia coli. Lancet (1968) 1.53
Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein. J Clin Endocrinol Metab (1986) 1.52
Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees. Hum Mol Genet (1996) 1.51
Time course of recovery of adrenal function in children treated for leukemia. J Pediatr (2000) 1.51
Transfusion-transmitted malaria in Canada. CMAJ (2001) 1.51
Elective segmental ureterectomy for transitional cell carcinoma of the ureter: long-term follow-up in a series of 73 patients. BJU Int (2012) 1.51
Mutation in the CYP21B gene (Ile-172----Asn) causes steroid 21-hydroxylase deficiency. Proc Natl Acad Sci U S A (1988) 1.50
Protein repletion and treatment in anorexia nervosa. Am J Clin Nutr (1994) 1.50
Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet (1995) 1.50
Treatment of an aneurysm of the coeliac axis by transluminal steel wire occlusion. Eur J Vasc Endovasc Surg (1997) 1.48
Brain kinins are responsible for the pressor effect of intracerebroventricular captopril in spontaneously hypertensive rats. Hypertension (1990) 1.48
Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation (1999) 1.48
Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol (1999) 1.47
Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med (1974) 1.47
CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity. J Neurol (1989) 1.46
Noninvasive management of obstructing ureteral stones using electromagnetic extracorporeal shock wave lithotripsy. Surg Endosc (2008) 1.46
Physiological carotid body denervation during aging. Adv Exp Med Biol (2009) 1.45
Mineralocorticoid hypertension and congenital deficiency of 11 beta-hydroxysteroid dehydrogenase in a family with the syndrome of 'apparent' mineralocorticoid excess. Clin Endocrinol (Oxf) (1995) 1.44
Notifying patients exposed to blood products associated with Creutzfeldt-Jakob disease: theoretical risk for real people. CMAJ (1998) 1.43
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42
Enhanced expression of transforming growth factor beta1 in rat thyroid hyperplasia is thyrotropin induced and time dependent. Eur J Endocrinol (1996) 1.41
Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest (1992) 1.40
Pancreatectomy abolishes the renal hemodynamic response to a meat meal in man. Nephron (1990) 1.40
Vi serology in the detection of typhoid carriers. Lancet (1981) 1.39
Reported seroconversions to human immunodeficiency virus among workers worldwide--a review. Can J Infect Control (1992) 1.39
Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study. Am J Hypertens (1998) 1.39
Diagnosis and treatment of thyroid nodules and goitre. J R Coll Physicians Lond (1998) 1.38
Congenital adrenal hyperplasia. (1). N Engl J Med (1987) 1.36
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics (1992) 1.33
The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem (1991) 1.33
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens (2001) 1.30
1alpha-Hydroxylase and the action of vitamin D. J Mol Endocrinol (2000) 1.30
Apparent cortisone reductase deficiency: a unique form of hypercortisolism. J Clin Endocrinol Metab (1996) 1.30
Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology (1999) 1.29
Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension (1999) 1.28
Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem (1990) 1.27
Kidney stones and hypertension: population based study of an independent clinical association. BMJ (1990) 1.26
Molecular genetic analysis of nonclassic steroid 21-hydroxylase deficiency associated with HLA-B14,DR1. N Engl J Med (1988) 1.26
Short term regulation of ureagenesis. J Biol Chem (1980) 1.26
Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction. Genomics (1995) 1.26
Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int (2008) 1.26